MEDCOSMETIC
Live / Registered — Registered (as of 04 Mar 2025)
What this means for you
Registered since 04 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98149091
- Registration number
- 7709774
- Mark type
- Stylized text
- Filed
- 24 Aug 2023
- Published for opposition
- 14 Jan 2025
- Registered
- 04 Mar 2025
- Attorney of record
- Ozelle Martin
Goods and services
- Class 005 — Pharmaceuticals: Medicated creams for treating dermatological conditions; Medicated serums for treatment of skin
- Class 044 — Medical, beauty and agricultural services: Facial treatment services, namely, cosmetic peels; Hair restoration services; Health spa services, namely, laser treatments for acne, rejuvenation, scars, tattoo removal and for facials and massage; Laser hair removal services; Laser skin rejuvenation services; Laser skin tightening services; Laser tattoo removal service; Microneedling treatment services; Providing laser and intense pulse light skin enhancement procedures; Providing medical aesthetic procedures, namely, treating the skin with dermal fillers and botulinum toxin
Owner
- MedCosmetic LLC., Overland Park, KS, US
- MedCosmetic LLC., Overland Park, KS, US
- MedCosmetic LLC., Overland Park, KS, US
Prosecution history
- 04 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION
- 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Jul 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 25 Jul 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 25 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Apr 2024 — NON-FINAL ACTION E-MAILED
- 25 Apr 2024 — NON-FINAL ACTION WRITTEN
- 24 Apr 2024 — ASSIGNED TO EXAMINER